clinical trial
Atyr Pharma Stock Crashes as Clinical Trial Misses Key Mark
Atyr Pharma shares collapsed after its pivotal Phase 3 trial for pulmonary sarcoidosis failed to meet expectations, triggering legal probes and investor turmoil.
Semaglutide Shows Promise in Treating Liver Disease MASH
A landmark phase 3 trial reveals semaglutide’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease affecting millions globally.
Immunotherapy Trial Offers New Hope for Cancer Patients
A groundbreaking immunotherapy trial shows potential to replace surgeries for certain cancer patients, preserving quality of life.
Experimental Drug Reduces Deadly Cholesterol by 94% in 2025 Study
A single dose of lepodisiran, an experimental drug, reduced lipoprotein(a) levels by 94% in a 2025 clinical trial, offering hope for millions at risk of heart disease.